Insider · CIK 0001587514
Scott Koenig
Files at MGNX (MACROGENICS INC). First filing -, latest -.
In brief
Scott Koenig files SEC Form 4 as CEO, president and director at MGNX (MACROGENICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Scott Koenig has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | MGNX MACROGENICS INC | AGrant or award Restricted Stock Unitderivative | +3,750 | $0.00 | $0 | 3,750 | May 20, 2026 |
| May 19, 2026 | MGNX MACROGENICS INC | AGrant or award Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | May 20, 2026 |
| Feb 15, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +21,165 | $0.00 | $0 | 867,240 | Feb 17, 2026 |
| Feb 15, 2026 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -21,165 | $0.00 | $0 | 0 | Feb 17, 2026 |
| Feb 8, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +15,831 | - | - | 846,075 | Feb 10, 2026 |
| Feb 8, 2026 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -15,831 | $0.00 | $0 | 15,832 | Feb 10, 2026 |
| Aug 13, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +21,165 | $0.00 | $0 | 798,580 | Aug 15, 2025 |
| Aug 13, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +31,664 | $0.00 | $0 | 830,244 | Aug 15, 2025 |
| Aug 13, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -21,165 | $0.00 | $0 | 21,165 | Aug 15, 2025 |
| Aug 13, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -31,664 | $0.00 | $0 | 31,663 | Aug 15, 2025 |
| Feb 15, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +42,329 | $0.00 | $0 | 777,415 | Feb 19, 2025 |
| Feb 15, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -42,329 | $0.00 | $0 | 42,330 | Feb 19, 2025 |
| Feb 8, 2025 | MGNX MACROGENICS INC | AGrant or award Common Stock | +31,673 | $0.00 | $0 | 735,086 | Feb 11, 2025 |
| Feb 8, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -31,673 | $0.00 | $0 | 63,327 | Feb 11, 2025 |
Questions about Scott Koenig
Answered from the filings on this page, as of the latest one.
Is Scott Koenig buying or selling?
Scott Koenig has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Scott Koenig's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott Koenig has 0.
Where does Scott Koenig file Form 4?
Scott Koenig has filed Form 4 at MGNX (MACROGENICS INC) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.